Pathology of lupus nephritis

Reading File

Finding Sources

Searching Images

lupus nephritis histology pathology

Searching PubMed

"lupus nephritis"[MeSH Terms] AND classification AND pathology

Reading File

Loading Image

Reading File

Loading Image

Reading File

Loading Image

Reading File

I now have comprehensive material to write a detailed, well-illustrated answer. Let me compile the full pathology of lupus nephritis.

Pathology of Lupus Nephritis

Lupus nephritis (LN) is the renal manifestation of systemic lupus erythematosus (SLE), which is the prototype of a human systemic immune complex (type III hypersensitivity) disease. Immune complexes composed of nuclear antigens and specific autoantibodies deposit in glomeruli, triggering complement activation and inflammatory cascade. Renal disease produces the greatest risk of morbidity and mortality in lupus patients. It is most common in Black females between 15–45 years of age, and in Asian populations where it accounts for >50% of secondary glomerular diseases in countries such as China, Korea, and Japan.

Pathogenesis

The central mechanism involves loss of tolerance to nuclear antigens. Key autoantibodies include:

Anti-dsDNA (most specific)
Anti-histone, anti-RNP, anti-Sm, anti-C1q, anti-endothelial antibodies

These form circulating immune complexes that deposit in glomeruli, or bind planted antigens in situ. Complement activation via the classical pathway (C1q → C3 → C5b–9 membrane attack complex) drives glomerular injury.

Pathogenesis of lupus nephritis — mesangial cell activation by anti-dsDNA IgG triggers complement fixation, IL-8 upregulation, miR-10a downregulation, mesangial proliferation, and phagocyte recruitment

Additional mechanisms include:

B- and T-lymphocyte abnormalities with loss of peripheral tolerance
Neutrophil extracellular traps (NETs) — provide a source of nuclear autoantigens
Defective apoptotic debris clearance → persistent antigenic stimulation
Macrophage and dendritic cell activation
Cytokine milieu (IL-6, IL-17, IFN-α, TNF-α)
Over 50 genetic polymorphisms linked to susceptibility, including CCR6 variants

ISN/RPS Classification (2003, revised 2018)

The International Society of Nephrology / Renal Pathology Society (ISN/RPS) classification divides LN into six classes based primarily on light microscopy (LM), immunofluorescence (IF), and electron microscopy (EM):

Class	Name	Key Histology	Clinical
I	Minimal mesangial	Normal LM; mesangial deposits on IF/EM only	Asymptomatic; normal urinalysis
II	Mesangial proliferative	Mesangial hypercellularity + matrix expansion; mesangial deposits	Mild proteinuria/hematuria; no nephrotic syndrome
III	Focal nephritis	Endocapillary ± extracapillary proliferation in <50% glomeruli	Variable; hematuria, proteinuria, possible renal insufficiency
IV	Diffuse nephritis	Endo ± extracapillary proliferation in ≥50% glomeruli; wire-loop lesions	Most severe; nephrotic + nephritic, hypertension, renal failure
V	Membranous nephritis	Diffuse subepithelial deposits; GBM thickening + spikes	Nephrotic syndrome; may coexist with III or IV
VI	Advanced sclerosing	>90% global glomerulosclerosis	ESKD; irreversible

Class III and IV lesions are qualitatively identical and differ only in the percentage of glomeruli involved (the threshold is 50%).

Class-by-Class Histopathology

Class I — Minimal Mesangial LN

LM: Normal-appearing glomeruli (normocellular, patent capillary lumens)
IF: Mesangial IgG (and often other immunoglobulins) deposits
EM: Small electron-dense deposits within mesangium
Rarely biopsied; patients are usually asymptomatic

Class I LN — normocellular glomerulus, PAS ×400 (Henry's Clinical Diagnosis)

Class I: Normal-appearing glomerulus on PAS (×400)

Class I LN — mesangial IgG on immunofluorescence ×400

Class I: Mesangial IgG staining on immunofluorescence (×400)

Class II — Mesangial Proliferative LN

LM: Mesangial hypercellularity with mesangial matrix expansion
IF: Mesangial deposits of IgG (± IgM, IgA, C3, C1q)
EM: Numerous electron-dense deposits within expanded mesangium
No capillary wall involvement
Clinical: Mild proteinuria or microscopic hematuria; almost never nephrotic syndrome or renal failure

Class III — Focal LN

LM: Endocapillary hypercellularity in <50% of glomeruli, often segmental; fibrinoid necrosis, karyorrhectic debris, ± crescents; PMN infiltration
IF: Focal mesangial and capillary wall deposits
EM: Mesangial and subendothelial electron-dense deposits
May include active (A), chronic (C), or mixed (A/C) lesions

Class III LN — segmental endocapillary hypercellularity with fibrinoid necrosis and karyorrhectic debris, Jones silver ×400

Class III: Segmental endocapillary hypercellularity with fibrinoid necrosis, Jones silver (×400)

Class IV — Diffuse LN (Most Common & Most Severe)

LM: Endocapillary (and often extracapillary) hypercellularity in ≥50% of glomeruli
- "Wire-loop" lesions — eosinophilic thickening of peripheral capillary walls due to massive subendothelial immune deposits enclosed by silver-positive GBM
- "Hyaline thrombi" (misnomer) — intraluminal immune complex deposits filling capillary lumens
- Karyorrhectic nuclear debris, monocyte infiltration, crescents
IF: Diffuse granular deposits of IgG, IgM, IgA, C3, C1q in mesangium and capillary walls — "full house" pattern; intense C1q staining is a helpful diagnostic clue
EM: Massive mesangial and subendothelial electron-dense deposits; may show tubular/fingerprint substructure; tubuloreticular inclusions (TRIs) in endothelial cytoplasm (induced by IFN-α)
Clinical: Hematuria + proteinuria + hypertension ± renal failure; red cell casts; nephrotic syndrome

Class IV LN — prominent subendothelial "wire-loop" deposits, silver-positive GBM enclosing eosinophilic material, Jones silver ×400

Class IV: Wire-loop subendothelial deposits enclosed by silver-positive GBM (Jones silver, ×400)

Class IV LN — diffuse strong IgG staining of mesangium and peripheral capillary loops on immunofluorescence ×400

Class IV: Strong IgG in mesangium and capillary loops — "full house" IF pattern (×400)

Class IV is further subclassified:

IV-S: diffuse segmental (>50% glomeruli, each with segmental lesions)
IV-G: diffuse global (>50% glomeruli, each with global lesions)

Class V — Membranous LN

LM: Diffuse thickening of glomerular capillary walls (spherical/rigid-loop appearance); mild mesangial hypercellularity
Silver stain: "Spikes" of GBM projecting between subepithelial deposits
IF: Diffuse granular IgG (± others) along capillary walls (subepithelial pattern)
EM: Prominent subepithelial electron-dense deposits; podocyte foot process effacement
May coexist with class III or IV ("mixed" membranous + proliferative)
Clinical: Severe proteinuria and nephrotic syndrome

Class VI — Advanced Sclerosing LN

LM: >90% global glomerulosclerosis — no residual activity
Represents end-stage, irreversible kidney disease (ESKD)

"Full House" Immunofluorescence

A hallmark of lupus nephritis across all classes is the "full house" IF pattern: simultaneous granular staining for IgG, IgM, IgA, C3, and C1q within glomeruli. The intense C1q staining is particularly characteristic. This multi-isotype, multi-complement deposition reflects activation of the classical pathway by DNA–anti-DNA immune complexes.

Tubulointerstitial and Vascular Lesions

LN can involve all renal compartments beyond the glomerulus:

Tubulointerstitial:

Immune complex deposits in tubular basement membranes (on IF/EM)
Tubulitis with lymphocytic infiltration
Tubular atrophy and interstitial fibrosis (chronicity markers)

Vascular lesions — several patterns are recognised:

Lupus vasculopathy — non-inflammatory immune complex deposits in vessel walls
Thrombotic microangiopathy (TMA) — fibrin thrombi, endothelial swelling, possibly related to antiphospholipid antibodies
True vasculitis — rare necrotising arteritis
Arteriosclerosis — chronic hypertensive changes

NIH Activity and Chronicity Indices

Separate scoring of individual lesions guides prognosis and treatment response:

Activity Index (AI) — total score 0–24 (scored 0–3+ each):

Lesion	Weight
Endocapillary hypercellularity	×1
Neutrophil infiltration	×1
Subendothelial hyaline deposits (wire loops)	×1
Fibrinoid necrosis/karyorrhexis	×2
Cellular crescents	×2
Interstitial inflammation	×1

Chronicity Index (CI) — total score 0–12 (scored 0–3+ each):

Lesion
Glomerular sclerosis
Fibrous crescents
Tubular atrophy
Interstitial fibrosis

High chronicity index predicts poor renal prognosis. These indices are used to assess response to therapy on repeat biopsies.

Lupus Podocytopathy

A separate entity not included in ISN/RPS classification. Presents with nephrotic syndrome in SLE patients but shows:

Normal glomeruli, FSGS, or mesangial proliferation on LM
No endocapillary hypercellularity or crescents
IF: No deposits or only mesangial deposits
EM: Severe diffuse podocyte foot process effacement without electron-dense deposits
Represents primary podocyte injury rather than immune complex deposition; high relapse rate

Progression and Clinical Correlations

Feature	Prognostic Implication
Class IV with crescents	Aggressive; requires prompt induction therapy
High AI	Active disease amenable to treatment
High CI	Irreversible damage; poor renal prognosis
Mixed class IV + V	More proteinuria; harder to treat
Crescentic LN	Associated with anti-neutrophil cytoplasm antibodies (ANCA) in Chinese patients
Vascular/endothelial lesions	Signify aggressive disease
Baseline creatinine >0.9 mg/dL + proteinuria >0.5 g/24h	Adverse prognostic markers

Recent Evidence (2024–2026)

A 2026 systematic review (PMID 41169181) in Arthritis & Rheumatology reviews serum and urinary biomarkers (including anti-dsDNA, complement, urinary CXCL10, TWEAK) that correlate with histopathologic class and activity indices, potentially enabling non-invasive disease monitoring. A 2025 meta-analysis (PMID 41142814) highlights IL-18 as an amplifier of immune-mediated nephropathy in LN. These studies do not alter the ISN/RPS classification or standard biopsy interpretation but underscore the need for biomarkers that reflect histologic activity without repeat biopsy.

Sources: Robbins & Kumar Basic Pathology (9780323790185); Henry's Clinical Diagnosis and Management by Laboratory Methods (9780323673204); Brenner and Rector's The Kidney (9780323532655); Comprehensive Clinical Nephrology 7e (9780323825924); National Kidney Foundation Primer on Kidney Diseases 8e (9780323791229)

This is a shared conversation. Sign in to Orris to start your own chat.